在宫癌中CXCL17的临床意义

Jingming Zhai1, Tianshu Pang1, Yanhui An2

  • 1Department of General Surgery, The First Affiliated Hospital and College of Clinical Medicine, Henan University of Science and Technology, Luoyang, China.

Medicine
|January 7, 2026
PubMed
概括

炎症性细胞因子CXCL17与子宫癌的进展有关. 这项研究发现CXCL17与晚期临床阶段相关,并通过影响表皮细胞到介质酶细胞过渡标记物来促进瘤的进展.